Home » Stocks » XXII

22nd Century Group, Inc. (XXII)

Stock Price: $1.51 USD 0.08 (5.59%)
Updated November 25, 4:00 PM EST - Market closed

Stock Price Chart

Key Info

Market Cap 209.68M
Revenue (ttm) 28.06M
Net Income (ttm) -19.50M
Shares Out 138.86M
EPS (ttm) -0.14
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day November 25
Last Price $1.51
Previous Close $1.43
Change ($) 0.08
Change (%) 5.59%
Day's Open 1.42
Day's Range 1.35 - 1.54
Day's Volume 1,715,113
52-Week Range 0.55 - 1.80

More Stats

Market Cap 209.68M
Enterprise Value 185.25M
Earnings Date (est) Mar 10, 2021
Ex-Dividend Date n/a
Shares Outstanding 138.86M
Float 136.89M
EPS (basic) -0.15
EPS (diluted) -0.14
FCF / Share -0.11
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 10.41M
Short Ratio 6.02
Short % of Float 7.60%
Beta 0.64
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 7.47
PB Ratio 3.75
Revenue 28.06M
Operating Income -20.29M
Net Income -19.50M
Free Cash Flow -15.57M
Net Cash 24.43M
Net Cash / Share 0.18
Gross Margin 0.05%
Operating Margin -72.30%
Profit Margin -69.50%
FCF Margin -55.50%
ROA -17.39%
ROE -37.03%
ROIC -38.80%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (1)

Buy 1
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$4.00*
Low
4.00
Current: $1.51
High
4.00
Target: 4.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue25.8326.4316.6012.288.520.537.280.021.010.05
Revenue Growth-2.25%59.19%35.18%44.1%1510.99%-92.73%38666.35%-98.15%1933.06%-
Gross Profit0.010.90-0.71-0.43-0.580.036.82-0.050.590.02
Operating Income-25.37-24.02-13.30-11.39-12.04-10.591.81-3.24-3.76-1.10
Net Income-26.56-7.97-13.03-11.58-11.03-15.60-26.15-6.74-1.35-1.42
Shares Outstanding12612410179.8468.1459.9943.6430.4226.3912.44
Earnings Per Share-0.21-0.06-0.13-0.15-0.16-0.26-0.60-0.22-0.05-0.11
Operating Cash Flow-14.59-17.84-12.07-9.89-7.32-6.583.86-1.76-3.45-0.91
Capital Expenditures-0.36-0.45-1.16-0.20-0.040.42-3.45--0.01-
Free Cash Flow-14.95-18.29-13.23-10.08-7.36-6.160.40-1.76-3.46-0.91
Cash & Equivalents38.9656.3562.6413.473.766.405.830.000.250.00
Total Debt1.481.54-0.310.621.100.172.691.421.34
Net Cash / Debt37.4954.8262.6413.163.145.305.66-2.69-1.17-1.33
Assets68.9577.3079.7427.6418.3721.9512.292.642.392.80
Liabilities6.906.024.313.316.646.734.768.783.604.89
Book Value62.0571.2875.4324.3311.7315.227.52-6.13-1.22-2.09
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name 22nd Century Group, Inc.
Country United States
Employees 67
CEO James A Mish

Stock Information

Ticker Symbol XXII
Stock Exchange NYSE American
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Unique Identifier NYSEAMERICAN: XXII

Description

22nd Century Group, a plant biotechnology company, provides technology that allows to alter the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. The company offers SPECTRUM research cigarettes for use in independent clinical studies; and very low nicotine content (VLNC) tobacco cigarettes under the Moonlight and Moonlight Menthol brands. It is also involved in contract manufacturing business for third-party branded tobacco products. The company has a strategic research and development agreement with Keygene N.V. to develop hemp/cannabis plants for medical, therapeutic, and agricultural uses, as well as for other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Williamsville, New York.